Check out our most popular compounded medications! Get Started
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is a specialized liquid formulation with suspended solid particles. It is designed for precise application using a dropper, delivering the medication directly to the nasal cavity. This localized treatment is used for conditions such as Allergic Rhinitis, Rhinitis, Sinusitis, Nasal Congestion, and Nasal Polyps.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is a compounded formulation designed to treat a range of nasal and sinus conditions. This includes Allergic Rhinitis, Rhinitis, Sinusitis, Nasal Congestion, and Nasal Polyps. The medication is a liquid formulation containing suspended solid particles, designed for precise and controlled application using a dropper applicator. This ensures the medication is delivered directly to the nasal cavity for localized treatment.
The medication works by reducing inflammation in the nasal passages and sinuses, as well as reducing the production of mucus. Beclomethasone Dipropionate is a corticosteroid that helps reduce inflammation, while Ipratropium Bromide is an anticholinergic that helps reduce the production of mucus.
At Bayview Pharmacy, we are dedicated to providing the highest quality compounded medications to meet your unique health needs. If you have any questions about Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension or any other medication, please reach out to us. Our knowledgeable pharmacists are here to help you find the best treatment for your condition.
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is a compounded formulation specifically designed for the treatment of various nasal conditions such as Allergic Rhinitis, Rhinitis, Sinusitis, Nasal Congestion, and Nasal Polyps. This unique formulation combines the potent anti-inflammatory properties of Beclomethasone Dipropionate with the anticholinergic effects of Ipratropium Bromide, providing a dual-action approach to symptom relief.
Beclomethasone Dipropionate is a powerful corticosteroid that works by reducing inflammation and swelling in the nasal passages, effectively alleviating the symptoms associated with allergic rhinitis, rhinitis, sinusitis, nasal congestion, and nasal polyps. On the other hand, Ipratropium Bromide is an anticholinergic agent that aids in reducing the production of mucus, further helping to alleviate nasal congestion.
This formulation is designed for precise and controlled application using a dropper applicator, ensuring optimal distribution and prolonged contact within the nasal cavity. While generally well-tolerated, it is important to note that this formulation should not be used for more than three consecutive days to avoid the risk of rebound congestion.
Some patients may experience a temporary burning or stinging sensation in the nose upon application. If these or any other side effects occur, it is recommended to contact a healthcare provider immediately. Furthermore, this formulation is not recommended for use in children under the age of 12.
As with any medication, it is crucial to use this formulation as directed by a healthcare provider and to reach out to a healthcare professional with any questions or concerns regarding its use.
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is a compounded medication specifically designed to treat a variety of nasal conditions including allergic rhinitis, rhinitis, sinusitis, nasal congestion, and nasal polyps. This unique formulation combines the anti-inflammatory properties of Beclomethasone Dipropionate, a corticosteroid, with the mucus-reducing capabilities of Ipratropium Bromide, an anticholinergic. Together, these active ingredients work synergistically to reduce inflammation and swelling in the nasal passages, decrease mucus production, and alleviate the discomfort associated with these conditions.
The medication is presented in a liquid suspension form, containing suspended solid particles. This format allows for precise and controlled application directly to the nasal cavity using a dropper applicator. The direct application ensures optimal distribution of the medication and prolonged contact with the affected area.
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is typically administered as a nasal spray. To use, the medication should be sprayed into each nostril once or twice daily, or as directed by a healthcare professional. It is crucial to shake the bottle before each use to ensure the suspension is well mixed. As with any medication, it should be used as directed by a healthcare professional, and any questions or concerns should be addressed with them.
Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension is a specialized compounded formulation designed for the treatment of various nasal conditions. The formulation is a combination of two potent medications, beclomethasone dipropionate and ipratropium bromide, which synergistically work to alleviate inflammation and congestion in the nasal passages.
Beclomethasone dipropionate is a corticosteroid that functions by reducing inflammation in the nasal passages. It works by suppressing the body's immune response, thereby reducing swelling, redness, and itching. On the other hand, ipratropium bromide is an anticholinergic medication that works by decreasing the production of mucus in the nasal passages, thereby reducing nasal congestion and improving breathing.
This unique combination of medications in the Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension effectively reduces the symptoms of allergic rhinitis, rhinitis, sinusitis, nasal congestion, and nasal polyps. The formulation is available as a nasal spray, designed for precise and controlled application using a dropper applicator. This ensures optimal distribution and prolonged contact of the medication within the nasal cavity.
It is important to use this formulation as directed by your healthcare provider to ensure its effectiveness and to minimize potential side effects. If you have any questions or concerns about the use of Beclomethasone Dipropionate 0.025%/Ipratropium Bromide 0.012% Nasal Suspension, it is recommended to consult with your healthcare provider or pharmacist.
This is a liquid formulation containing suspended solid particles of Beclomethasone Dipropionate and Ipratropium Bromide. It is designed for precise and controlled application using a dropper applicator, delivering medication directly to the nasal cavity for localized treatment of nasal conditions.
The medication works by ensuring optimal distribution and prolonged contact within the nasal cavity.
You should use the dropper applicator provided with the medication to apply the suspension directly into your nasal cavity. Follow your healthcare provider's instructions regarding the dosage and frequency of use.
This nasal suspension is used for the localized treatment of various nasal conditions. However, the specific conditions it treats will depend on your healthcare provider's diagnosis and prescription.
The active ingredients in this nasal suspension are Beclomethasone Dipropionate and Ipratropium Bromide.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Like all medications, this nasal suspension can have side effects. If you experience any unusual symptoms or reactions after using the suspension, contact your healthcare provider immediately.
If you are pregnant or breastfeeding, you should consult your healthcare provider before using this nasal suspension. They will be able to advise you on the potential risks and benefits.
Before starting any new medication, including this nasal suspension, you should inform your healthcare provider about all the medications you are currently taking. This includes prescription medications, over-the-counter drugs, and dietary supplements.
Store this nasal suspension in a cool, dry place away from direct sunlight. Keep it out of reach of children and pets. Do not use it past its expiry date.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Inhale into nostril(s)
